Vutrisiran
Vutrisiran Uses, Dosage, Side Effects, Food Interaction and all others data.
Vutrisiran is an investigational RNAi therapeutic in development for the treatment of transthyretin-mediated (ATTR) amyloidosis, which encompasses both hereditary ATTR (hATTR) amyloidosis and wild-type ATTR (wtATTR) amyloidosis.
| Trade Name | Vutrisiran |
| Generic | Vutrisiran |
| Vutrisiran Other Names | Votrisiran, Vutrisiran |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Vutrisiran
